Physician profile
Joseph A Brown
NPI 1356320881
$4,834.04
in general payments reported to CMS, 2019-2025
23 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $819 · 2020: $619 · 2021: $678 · 2022: $677 · 2023: $732 · 2024: $527 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,942.33 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,370.05 | 2019-2025 | Stelara, Tremfya, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $993.61 | 2019-2023 | Xifaxan |
| Abbvie INC. | $660.95 | 2019-2025 | Viberzi, Linzess |
| Gilead Sciences, INC. | $359.89 | 2019-2025 | |
| Evoke Pharma, INC. | $308.81 | 2021-2024 | Gimoti |
| Ucb, INC. | $126.18 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $122.79 | 2019-2021 | |
| Allergan, INC. | $100.90 | 2019-2020 | |
| Celgene Corporation | $98.39 | 2022-2024 | Zeposia |
| Celltrion USA INC. | $88.59 | 2025 | Vegzelma |
| Daiichi Sankyo INC. | $86.73 | 2020-2022 | |
| Ardelyx, INC. | $83.41 | 2023-2025 | Ibsrela |
| Ironwood Pharmaceuticals, INC | $75.30 | 2019-2021 | |
| Braintree Laboratories, INC. | $45.54 | 2020-2023 | Sutab |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $33.97 | 2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $29.23 | 2020-2023 | |
| Mallinckrodt Hospital Products INC. | $29.09 | 2022-2023 | Terlivaz |
| Intercept Pharmaceuticals, INC. | $28.64 | 2020-2021 | |
| Lundbeck LLC | $28.26 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.26 | 2023 | Rebyota |
| Shire North American Group INC | $13.28 | 2019 | |
| Ambu INC. | $10.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.